Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The9 ( (NCTY) ) has provided an announcement.
On October 2, 2025, The9 Limited announced that its Singapore investee company, Nanyang Biologics (NYB), plans to go public on Nasdaq through a $1.5 billion business combination with RF Acquisition Corp II. This strategic move is expected to enhance NYB’s capabilities in AI-driven drug discovery, particularly in oncology, by leveraging partnerships with Nvidia, HP, and Equinix. The transaction, anticipated to close in the first half of 2026, will see NYB’s shareholders, including The9, retain a majority stake, potentially positioning NYB as a leader in AI and biotechnology.
More about The9
The9 Limited is a Nasdaq-listed Internet company, established in 2004, focused on becoming a global diversified high-tech Internet company. It operates in online games, Bitcoin mining, and AI-driven drug discovery investments.
Average Trading Volume: 56,367
Technical Sentiment Signal: Sell
Current Market Cap: $132.4M
See more data about NCTY stock on TipRanks’ Stock Analysis page.